| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Soergel David Chief Medical Officer | Sale | -1,042 | -9.41%10,033 | $495.74 | $516,561 | View SEC filing | |
| 2026-05-22 | Levy Richard S Director | Sale | -5,682 | -20.51%22,015 | $515.44 | $2,928,716 | View SEC filing | |
| 2026-05-18 | Soergel David Chief Medical Officer | Sale | -844 | -7.08%11,075 | $515.90 | $435,420 | View SEC filing | |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale | -1,982 | -13.70%12,490 | $430.87 | $853,993 | View SEC filing | |
| 2026-03-06 | Sibold William John President and CEO | Sale | -1,663 | -1.02%161,829 | $431.94 | $718,316 | View SEC filing | |
| 2026-03-06 | Kelley Shannon T General Counsel | Sale | -360 | -2.88%12,138 | $431.94 | $155,498 | View SEC filing | |
| 2026-03-06 | Huntsman Carole Chief Commercial Officer | Sale | -419 | -3.20%12,692 | $431.94 | $180,983 | View SEC filing | |
| 2026-03-06 | Taub Rebecca Director | Sale | -491 | -0.11%452,213 | $431.94 | $212,083 | View SEC filing | |
| 2026-03-02 | Dier Mardi EVP and CFO | Sale | -1,183 | -11.33%9,257 | $427.21 | $505,389 | View SEC filing | |
| 2026-01-26 | Huntsman Carole Chief Commercial Officer | Sale | -910 | -9.07%9,122 | $493.78 | $449,339 | View SEC filing | |
| 2026-01-26 | Sibold William John President and CEO | Sale | -1,577 | -1.05%148,497 | $492.42 | $776,546 | View SEC filing | |
| 2026-01-26 | Taub Rebecca Director | Sale | -647 | -0.14%452,704 | $492.42 | $318,596 | View SEC filing | |
| 2026-01-20 | Kelley Shannon T General Counsel | Sale | -692 | -7.54%8,481 | $497.36 | $344,173 | View SEC filing | |
| 2026-01-20 | Taub Rebecca Director | Sale | -2,238 | -0.49%453,351 | $490.77 | $1,098,343 | View SEC filing | |
| 2026-01-13 | FRIEDMAN PAUL A Director | Sale | -280 | -0.15%187,164 | $551.24 | $154,348 | View SEC filing | |
| 2026-01-13 | FRIEDMAN PAUL A Director | Sale | -24,520 | -11.58%187,164 | $522.39 | $12,808,957 | View SEC filing | |
| 2026-01-13 | Taub Rebecca Director | Sale | -240 | -0.05%455,589 | $550.33 | $132,080 | View SEC filing | |
| 2026-01-13 | Taub Rebecca Director | Sale | -18,410 | -3.88%455,589 | $522.40 | $9,617,312 | View SEC filing | |
| 2025-12-12 | FRIEDMAN PAUL A Director | Sale | -24,800 | -11.70%187,164 | $552.18 | $13,694,158 | View SEC filing | |
| 2025-12-12 | Taub Rebecca Director | Sale | -18,650 | -3.89%461,044 | $552.15 | $10,297,573 | View SEC filing | |
| 2025-12-04 | Sibold William John President and CEO | Sale | -2,400 | -1.57%150,074 | $575.34 | $1,380,816 | View SEC filing | |
| 2025-12-03 | Dier Mardi EVP and CFO | Sale | -4,173 | -28.56%10,440 | $578.34 | $2,413,416 | View SEC filing | |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale | -1,958 | -16.33%10,032 | $553.11 | $1,082,986 | View SEC filing | |
| 2025-11-14 | Levy Richard S Director | Sale | -8,500 | -28.62%21,197 | $520.96 | $4,428,198 | View SEC filing | |
| 2025-11-07 | BATE KENNETH Director | Sale | -16,575 | -86.32%2,627 | $484.30 | $8,027,354 | View SEC filing |
1-25 of 201
